-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUPHORIA THERAPEUTICS - CONFIRMS DISCUSSIONS ON POTENTIAL ACQUISITION BY SCANCELL, WHICH WOULD BECOME NASDAQ-LISTED

Reuters·06/26/2026 20:24:29

Please log in to view news